May 28, 2026 04:01PM

May 14, 2026 08:35AM

Mar 30, 2026 09:24AM

Nov 24, 2025 08:55AM

Sep 26, 2025 06:00AM

Sep 25, 2025 02:35AM

Jul 31, 2025 06:17AM Biogen signals Leqembi sales gaining momentum, lifts profit forecast

Jul 20, 2025 08:00PM

Jun 13, 2025 11:43AM

Dec 9, 2024 04:32AM

Oct 30, 2024 08:18AM

Aug 1, 2024 06:50AM

Apr 24, 2024 06:48AM

Apr 1, 2024 06:40AM Biogen's (BIIB) Leqembi filing setback 'negative for sentiment'

Apr 28, 2023 02:00AM

Mar 29, 2023 06:01PM

Feb 15, 2023 08:08AM

Jan 5, 2023 11:50AM

Oct 25, 2022 09:02AM

Sep 19, 2022 10:33AM

Sep 19, 2022 07:58AM Jefferies Reiterates Buy Rating on Biogen (BIIB) Into Phase III CLARITY-AD Readout

Jun 8, 2022 11:50AM

Jun 8, 2022 11:41AM

Jan 12, 2022 09:29AM

Jan 4, 2022 08:15AM

Oct 20, 2021 07:07AM

Oct 13, 2021 09:02AM

Oct 8, 2021 08:03AM Biogen (BIIB) PT Lowered to $400 After Speaking with Management, Jefferies Sees Street Consensus as Too High

Sep 22, 2021 08:52AM

Aug 9, 2021 09:21AM

Jul 13, 2021 09:43AM

Jun 23, 2021 09:01AM

Jun 21, 2021 09:47AM

Jun 14, 2021 07:58AM

Jun 8, 2021 09:54AM Jefferies Expects a 25% Move in Athira Pharma (ATHA) Post Aducanumab Approval

Jun 8, 2021 09:08AM

Jun 7, 2021 11:47AM

Jun 4, 2021 08:27AM

Apr 19, 2021 08:07AM

Mar 16, 2021 07:55AM

Mar 15, 2021 02:14PM

Jan 29, 2021 08:43AM Jefferies Names Possible Hedge Fund Short Targets

Jan 25, 2021 08:25AM

Nov 9, 2020 08:06AM

Nov 4, 2020 01:09PM

Jun 18, 2020 09:26AM

Dec 13, 2019 03:30PM

Oct 22, 2019 01:45PM

Mar 21, 2019 03:43PM Biogen (BIIB) May Need More M&A Following AD Failure - Analysts

Feb 7, 2019 09:27AM

73,286 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All